2018
DOI: 10.2106/jbjs.17.01508
|View full text |Cite
|
Sign up to set email alerts
|

Allograft Compared with Autograft in Osteochondral Transplantation for the Treatment of Osteochondral Lesions of the Talus

Abstract: Background: There is a paucity of clinical studies that compare the efficacy of autograft and allograft in osteochondral transplantation for treatment of osteochondral lesions of the talus (OLT). The purpose of the present study was to compare the clinical and radiographic outcomes following osteochondral transplantation with autograft or allograft for OLT. Methods: A retrospective analysis comparing patients treated with autograft or allograft for OLT … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
52
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 47 publications
(53 citation statements)
references
References 25 publications
1
52
0
Order By: Relevance
“…65 Interestingly, autograft OCT also yielded a significantly improved ankle function and superior Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score compared with allograft OCT at about 2 years postoperatively, in good agreement with the significantly higher rate of clinical failures following allograft (25%, 4/16) compared with autograft OCT (0%, 0/25). 65 Shimozono et al also compared the postoperative incidence of cysts in ankle autograft OCT without or with concentrated BMA with a 60 months' follow-up. 66 The cyst incidence was significantly lower in autograft OCT with concentrated BMA (46.4%, 13/28) than in OCT without concentrated BMA (76.9%, 20/26).…”
Section: Subchondral Bone Cyst Formation In Other Jointssupporting
confidence: 59%
See 2 more Smart Citations
“…65 Interestingly, autograft OCT also yielded a significantly improved ankle function and superior Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score compared with allograft OCT at about 2 years postoperatively, in good agreement with the significantly higher rate of clinical failures following allograft (25%, 4/16) compared with autograft OCT (0%, 0/25). 65 Shimozono et al also compared the postoperative incidence of cysts in ankle autograft OCT without or with concentrated BMA with a 60 months' follow-up. 66 The cyst incidence was significantly lower in autograft OCT with concentrated BMA (46.4%, 13/28) than in OCT without concentrated BMA (76.9%, 20/26).…”
Section: Subchondral Bone Cyst Formation In Other Jointssupporting
confidence: 59%
“…Due to its high incidence (38.5% in microfracture 58 ; 38.8% in ACI 59 ; 38.9% in allograft OCT 62 ; 62.5% in allograft OCT 65 ; 76.9% in autograft OCT 66 ) and lasting presence (over 12 years reported for ACI 59 ), subchondral bone cyst formation following articular cartilage repair merits serious attention. Its appearance as early as 6 months postoperatively in over 15% of patients treated with microfracture 58 and 20% of patients treated with OCT 63,64 highlights the clinical importance.…”
Section: Clinical Implications and Outlookmentioning
confidence: 99%
See 1 more Smart Citation
“…Hu et al 11 used osteoperiosteal cylinder grafts from the iliac crest, which also resulted in good clinical outcomes. Shimozono et al 23 retrospectively reviewed the use of autologous grafts in 25 patients and the use of allogeneic bone in 16 patients. Over an average follow-up of 2 years, the autografts provided better clinical and MRI outcomes than the allografts.…”
Section: Discussionmentioning
confidence: 99%
“…Collectively, these disadvantages have made way for the development of bone graft extenders (reviewed in [ 9 ]). Their ease of use and unlimited quantities are two major advantages, but all allogeneic bone graft extenders must undergo deproteinization and decellularization to ensure immune-compatibility [ 10 ], Since they are devoid of stem/osteoprogenitor cells, and pro-osteogenic proteins, new bone tends to form very slowly around allografts [ 11 , 12 ]. This delayed graft incorporation is problematic and contributes to greater variability in clinical outcomes when allografts are used [ 13 ].…”
Section: Introductionmentioning
confidence: 99%